TrovaGene, Inc. (symbol: TROV) is on a winning streak, it has risen in 9
out of the last 10 trading days as of 2015-11-25. The average dialy change
was 2.744%. In terms of volume of shares changing hands, it averaged
407,927 vs. the usual 466,388
The closing price was $6.98, amounting to a market cap of $207,460,000. The
stock has been trading at a range between $4.12 and $13.58.
TROV is in the Biotechnology: Biological Products (No Diagnostic
Substances) industry. Analyst expect it to earn $-1.05 per share this year,
and $-1.21 next year. The 1-year target price is expected to be $10.2
No comments:
Post a Comment